Alkermes plc risk profile

45 Elevated one input has moved against it

Measured 21 October 2026 from ALKS's filed statements. Recomputed nightly.

45 (Elevated), driven by Concentration at 92, over 7 weighted categories on the MANUFACTURER profile.

What is measured

MechanismReadingBandDirectionDriver
Market expectation43ElevatedStableOne-year price volatility — 41.1%
Operating pressure45ElevatedWorseningCosts outgrowing revenue — +12.8 percentage points
Cash conversion10ContainedEasingCapital spending against operating cash — 0.08x
Leverage and coverage3ContainedStableCurrent ratio — 3.55x
Competitive position38NormalStableRevenue-growth gap against peers — +1.8 percentage points
Concentration92AcuteStableGeographic concentration — 8,700 HHI

These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.

Healthcare companies with a risk reading

Financials, valuation and price history for Alkermes plc